-
January 30, 2012
U.S. FDA approves Roche skin cancer drug
-
January 24, 2012
Kids seek tans, use less sunscreen as they age
NEW YORK (Reuters Health) - As kids go from elementary to junior high school ages, the desire to tan gets stronger while the habit of using sun protection gets tossed out the window, according to a survey that tracked kids' attitudes about the sun over three years.
-
January 19, 2012
U.S. indoor tanning tax having mixed effects
NEW YORK (Reuters Health) - Although a 2010 federal excise tax was meant to deter customers from using indoor tanning salons, only a minority of the businesses taking part in a new survey reported a drop in clients and most said their customers did not seem to care.
-
January 19, 2012
Packaging may pump-up kids' sunscreen use
NEW YORK (Reuters Health) - Kids using a pump dispenser applied the most sunscreen in a new Australian study, but they still used less than half the amount needed for full protection.
-
January 19, 2012
Roche melanoma pill spurs growth of other cancers
CHICAGO (Reuters) - A new study helps explain why up to a third of advanced melanoma patients who take Roche Holding's pill Zelboraf develop a less deadly form of skin cancer known as cutaneous squamous cell carcinoma, and points to a potential fix.
-
December 19, 2011
Tanning lotion users more likely to stay out of sun
NEW YORK (Reuters Health) - Women who use sunless tanning lotions and gels tend to cut back on outdoor sunbathing and trips to tanning beds, according to a new study from Georgia.
-
December 13, 2011
Indoor tanning tied to common skin cancers: study
-
December 7, 2011
Some men can delay prostate cancer treatment-panel
CHICAGO (Reuters) - Men with low-risk prostate cancer may wait to see if their disease progresses before treating it, an independent panel of experts convened by the U.S. National Institutes of Health (NIH) said on Wednesday.
-
November 30, 2011
Skin cancer rate may be higher in high-radon areas
NEW YORK (Reuters Health) - Rates of one form of skin cancer may be elevated in areas with naturally high levels of the radioactive gas radon, a UK study suggests.
-
October 17, 2011
Should your hairdresser screen you for skin cancer?
NEW YORK (Reuters Health) - Next time you get a haircut, you might end up with something you didn't expect: a referral to a dermatologist.
-
October 14, 2011
UK cost agency rejects Bristol-Myers' skin cancer drug
LONDON (Reuters) - Bristol-Myers Squibb's Yervoy -- the first drug to help patients with advanced melanoma live longer -- is not cost effective for use in the taxpayer-funded National Health Service (NHS), Britain's health costs watchdog said on Friday.
-
October 10, 2011
California bans use of tanning beds by minors
LOS ANGELES (Reuters) - Minors in the state of California will no longer be allowed to use tanning beds after Governor Jerry Brown signed a bill on Sunday prohibiting anyone under the age of 18 from using ultraviolet tanning devices.
-
September 22, 2011
Skin doctors head to sunnier pastures
NEW YORK (Reuters Health) - Certain areas of the United States, including the Midwest and Mountain regions, have an especially hard time holding on to dermatologists, according to a new study.
-
August 22, 2011
Seattle Genetics cancer drug price may top $100,000
WASHINGTON (Reuters) - The price of Seattle Genetics Inc's blood cancer drug Adcetris could top $100,000 for a course of treatment, becoming the latest cancer medicine to come at a high cost.
-
August 17, 2011
REFILE: FDA approves Roche skin cancer drug Zelboraf
WASHINGTON (Reuters) - U.S. drug regulators on Wednesday approved a targeted skin cancer drug from Roche Holding along with its diagnostic test, an advance in personalized health care.
-
August 9, 2011
REFILE: US approval of Roche melanoma drug may come early
LOS ANGELES (Reuters) - U.S. regulators are moving quickly with Roche's application for targeted melanoma drug vemurafenib, which could receive approval as early as this week, according to a source familiar with the situation.
-
August 9, 2011
US approval of Roche melanoma drug may come early
LOS ANGELES (Reuters) - U.S. regulators are moving quickly with Roche's application for targeted melanoma drug vemurafenib, which could receive approval as early as this week, according to a source familiar with the situation.
-
July 18, 2011
Hispanics still lagging in sun-safe behaviors
NEW YORK (Reuters Health) - Hispanics shouldn't assume their darker skin means they can't get skin cancer, and they should make sure to protect themselves when they're out in the sun, according to a new report.
-
June 30, 2011
Skin lesion risk seen at moderate arsenic levels
NEW YORK (Reuters Health) - High arsenic exposure is known to be a risk factor for skin cancer, but a new study suggests that even more-moderate exposure through drinking water may boost the risk of pre-cancerous skin growths.
-
June 30, 2011
Roche undeterred after FDA's Avastin rebuff
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG had nothing to lose by giving Avastin another roll of the dice, and by doing so showed the world it still believes the drug should be used in breast cancer.
-
June 29, 2011
US FDA panel rejects Avastin for breast cancer use
SILVER SPRING, Md. (Reuters) - U.S. health advisers delivered a blow to Roche Holding on Wednesday, voting to reject the use of Roche Holding drug Avastin for breast cancer while the Swiss drugmaker conducts more studies.
-
June 28, 2011
Kids who survive cancer more often get new tumors
NEW YORK (Reuters Health) - Children who have beaten cancer once are at increased risk of developing new tumors down the road, researchers say.
-
June 28, 2011
U.S. hears Roche on Avastin for breast cancer
SILVER SPRING, Md. (Reuters) - Breast cancer patients testified that Roche Holding AG's drug Avastin saved their lives as U.S. health officials consider whether the world's best-selling cancer drug should still be approved for that condition.
-
June 27, 2011
Can vitamin D lower your risk of melanoma?
NEW YORK (Reuters Health) - Taking vitamin D may help protect women who have already had non-melanoma skin cancers against a much deadlier form of the disease, suggests a new study.
-
June 14, 2011
Sunscreen label changes aim to reduce cancer risk
CHICAGO (Reuters) - Sunscreens that claim to reduce the risk of skin cancer will need to protect against both ultraviolet A and B rays and have a sun protection factor (SPF) of 15 or higher, according to new U.S. rules issued on Tuesday.
-
June 6, 2011
Evidence backs melanoma-Parkinson's association
NEW YORK (Reuters Health) - People with Parkinson's disease are twice as likely as those without the neurological disorder to get a diagnosis of the skin cancer melanoma, a new review of the evidence concludes.
-
June 6, 2011
Next up for melanoma treatment: drug cocktails
CHICAGO (Reuters) - Executives from Bristol-Myers Squibb and Roche Holding AG huddled around a desk at New York's Memorial Sloan-Kettering Cancer Center about six weeks ago to iron out details of a novel clinical trial.
-
June 6, 2011
New melanoma drugs improve chances of survival
CHICAGO (Reuters) - Two new drugs using very different scientific approaches can extend survival among patients with the deadliest form of skin cancer, offering the first new hope for real progress in many years.
-
June 3, 2011
Some success seen with personalized cancer treatment
CHICAGO (Reuters) - Tailoring cancer drugs to target the molecular signature of an individual patient's tumor helps more than a scattershot approach, according to early-stage research.
-
June 2, 2011
Bristol, Roche team up on melanoma study
NEW YORK (Reuters) - Bristol-Myers Squibb and Roche Holding AG said on Thursday they would evaluate their respective cancer drugs as a potential combination therapy for metastatic melanoma.
-
May 26, 2011
Roche upbeat on Avastin in ovarian cancer
ZURICH (Reuters) - Roche Holding AG, the world's leader in oncology drugs, struck an upbeat tone about approval prospects for its key drug Avastin in ovarian cancer ahead of an important industry meeting next month.
-
May 25, 2011
Study finds way to get antibody therapies into brain
CHICAGO (Reuters) - Scientists have found a way to get antibody-based therapies across a key barrier in the brain and deliver a payload of drugs that take aim at an elusive Alzheimer's target.
-
May 11, 2011
Selenium doesn't prevent cancer: report
NEW YORK (Reuters Health) - There is no convincing evidence that taking high doses of selenium -- a popular dietary supplement -- can prevent cancer, according to a new review.
-
May 9, 2011
Acetaminophen tied to blood cancers
NEW YORK (Reuters Health) - New research shows chronic users of acetaminophen, a top-selling painkiller known as Tylenol in the U.S. and paracetamol in Europe, are at slightly increased risk for blood cancers.
-
April 18, 2011
Many parents would get gene tests for kids: study
CHICAGO (Reuters) - If given the chance, many parents would test their children to see if they are genetically predisposed to diseases like diabetes or heart disease, U.S. researchers said on Monday.
-
April 1, 2011
Can painkillers prevent melanoma?
NEW YORK (Reuters Health) - New findings add to confusion over whether taking aspirin, ibuprofen or related painkillers reduces the risk of developing melanoma.
-
March 23, 2011
Genome study brings blood cancer into sharp focus
CHICAGO (Reuters) - Scientists have mapped out the full genetic code of 38 people with multiple myeloma, uncovering never-before suspected genes that play a role in the blood cancer and showing that a promising new drug might help.
-
March 23, 2011
Arthritis drug could help beat deadly skin cancer
LONDON (Reuters) - Scientists seeking treatments for a deadly type of skin cancer say an existing arthritis drug slows the growth of melanomas and could be combined with a drug being developed by Plexxikon and Swiss drugmaker Roche.
-
March 21, 2011
Melanoma rates higher in wealthy white women
NEW YORK (Reuters Health) - Adolescent girls and young women living in wealthy communities were more likely to be diagnosed with melanoma in a new study of skin cancer cases in California.
-
February 27, 2011
Doctors urge indoor tanning ban for minors
NEW YORK (Reuters Health) - U.S. tanning salons should close their doors to minors to protect them from skin cancer, a group of 60,000 pediatricians said Monday in a new policy statement.
-
February 16, 2011
Elizabeth Taylor improves, remains in hospital
LOS ANGELES (Reuters) - Elizabeth Taylor's medical condition is improving, but the Hollywood film legend will remain hospitalized for the foreseeable future, her spokeswoman said on Tuesday.
-
February 11, 2011
Will young doctors recognize melanoma?
NEW ORLEANS (Reuters Health) - Fourth-year medical students - at least those at the University of Illinois at Chicago -- are not very proficient at detecting melanomas, the most serious type of skin cancer, researchers from that school said this week at the 69th annual meeting of the American Academy of Dermatology.
-
February 7, 2011
Sun exposure and vitamin D linked to MS risk
NEW YORK (Reuters Health) - People who have spent more time in the sun and those with higher vitamin D levels may be less likely to develop multiple sclerosis (MS), according to a new study from Australia.
-
January 24, 2011
Blocking "rogue gene" may stop cancer spread-study
LONDON (Reuters) - British scientists have discovered a "rogue gene" which helps cancer spread around the body and say blocking it with the right kind of drugs could stop many types of the disease in their tracks.
-
January 19, 2011
Roche melanoma drug helps patients live longer
ZURICH (Reuters) - Swiss drugmaker Roche's new treatment for advanced skin cancer helps patients live longer and also extends the period in which their disease does not get worse, a late-stage trial has shown.
-
January 18, 2011
Skin creams may not protect against all UV light
NEW YORK (Reuters Health) - Many daily skin creams that claim to provide ultraviolet protection and anti-aging benefits may not have enough of the critical ingredients needed to block UV-A light, according to new research.
-
December 21, 2010
Many ignore indoor tanning risks
NEW YORK (Reuters Health) - Too many Americans are ignoring the dangers of indoor tanning, or they are unaware of the dangers, as evident by the number of people who do it and the fact that most don't acknowledge it increases their risk of skin cancer.
-
December 6, 2010
Study confirms sunscreen prevents melanoma
WASHINGTON (Reuters) - Adults who regularly use sunscreen are far less likely to develop melanoma, the deadliest form of skin cancer, researchers reported on Monday.
-
November 26, 2010
New Australia phone app aims to fight skin cancer
SYDNEY (Reuters Life!) - iPhone users enjoying the sunshine can now know when it's time to cover up and avoid potentially cancer-causing ultraviolet rays thanks to a new application called "SunSmart," produced by the Cancer Council Australia.
-
November 24, 2010
Studies show how skin cancer evades promising drug
CHICAGO (Reuters) - U.S. researchers have uncovered several ways in which melanoma can outsmart a promising experimental cancer pill called PLX4032, a finding that could lead to new drugs to keep the deadly skin cancer at bay, the teams said on Wednesday.